SCHEMBL20214481

SCHEMBL20214481

CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O[PH](=O)O)[C@@H](CO)O[C@H]1c1cnn2c(Nc3ccccc3)ncnc12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 15/20 0.37
▸ LMNA P02545 2/20 0.33
▸ SLC29A1 Q99808 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ NPY1R P25929 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPY2R P49146 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ THPO P40225 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21073968 0.88 — —
SCHEMBL25495879 0.88 — —
SCHEMBL25495885 0.83 — —
SCHEMBL20214586 0.78 — —
SCHEMBL20214499 0.78 ADK (0.36) ADKLMNASLC29A1ALDH1A1GLA
SCHEMBL25495889 0.77 LGALS9 (0.35) SLC29A1
SCHEMBL20214747 0.74 TAS1R3 (0.33) —
SCHEMBL25680127 0.73 — —
SCHEMBL25495888 0.72 PTPN1 (0.32) LMNAALDH1A1RAB9ATSHR
SCHEMBL25495999 0.71 TMPRSS2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512861-A2 CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTEFERON GENES) AGONISTS Takeda Pharmaceutical Company Limited (JP) 2019-07-24 — — EP disclosed
WO-2018100558-A2 CYCLIC DINUCLEOTIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-06-07 — — WO disclosed
Send feedback